LUC-studenten onderzoeken rivierherstel in de Geul met sedimentonderzoek, waterkwaliteitsmetingen en analyse van biodiversiteit

In October and December 2021, Al-Babtain Visiting Professor Hugh Kennedy will teach six masterclasses at Leiden University on the idea of a “Greater Mesopotamia” and its fundamental importance in understanding the economy and geopolitics of the early Islamic world, from 650 to 1050 CE.

Lezing

Dit was het programma van De Kennisboomgaard 2025:

In this dissertation (titled: Exploring the Synergies between Transfer in Reinforcement Learning and Procedural Content Generation) we explore how the two research fields named in the title, namely Transfer in Reinforcement Learning (TRL) and Procedural Content Generation (PCG) can synergize togethe…

Kunst en vrije tijd, Kunst en vrije tijd

Per 1 juli 2016 is mr. dr. J.E. (Jacobine) van den Brink benoemd als hoogleraar Europees en nationaal bestuursrecht aan Maastricht University. Momenteel is zij werkzaam als universitair docent bij de afdeling Staats- en bestuursrecht, Universiteit Leiden.

Promotie

Promotores: R. Tijdeman, K.J. Batenburg

The aim of this thesis is to present novel techniques for proving cryptographic schemes secure against quantum adversaries. Most results are within the context of an idealized model called the ‘quantum random-oracle model’.

Viral diseases constitute one of the major challenges in modern medicine. Membrane-targeting have broad-spectrum potential and could distinguish viral membranes from the host cell plasma membrane by the difference in membrane curvature.

Risk has become one of the defining features of modern society. This course examines various types of safety and security risks, and how these are perceived and dealt with in a wide array of professional and academic fields, ranging from criminology, counter-terrorism and cyber security, to philosophy,…

Promotor: Prof.dr. M.A.G.J. Orrit

This dissertation presents a new perspective on the life, work and character of the Dutch physical chemist Jacobus Henricus van ’t Hoff, first recipient of the Nobel Prize in Chemistry, and one of the most important and colourful scientists in Dutch history. The image of Van ’t Hoff that emerges from…

Promotor: A. Achúcarro, Co-Promotor: J.W. van Holten

Climate change is a challenge for both current and future generations. New biological resources have to be developed in order to meet the demand for energy as well as the demand for food.

In the last decades, activity-based protein profiling (ABPP) has emerged as a powerful chemical tool that may aid the ever-challenging drug discovery process.

Dynamical systems describe the evolution of objects in a space over time and may be used to model physical phenomena. Due to this, much research is dedicated to understanding the mathematics of dynamical systems.

This thesis presents the systematics, epidermal defense, and bioprospecting of wild orchids.

Discovery and development of Central Nervous System (CNS) drugs is hampered by high attrition rates.

Aan het LUCL pogen onderzoekers om de taaldiversiteit van de inheemse bevolking van Amerika te begrijpen, te bestuderen en te behouden.

The glycosylation reaction is a pivotal reaction in creating new and complex oligosaccharides.

Mechanical metamaterials are man-made materials which derive their unusual properties from their structure rather than their composition.

The upscaling of Life Cycle Assessment (LCA) data is recognized as one of the main challenges in the ex-ante LCA of emerging technologies. This challenge arises since industrial-scale system specifications for these technologies are unknown and industrial data is lacking.

Multicopper oxidase, laccase, can efficiently reduce oxygen to water and are mostly used in the enzymatic biofuel cells.

This dissertation explores how we can make anomaly detection—identifying unusual or faulty behavior in complex systems—more trustworthy and effective, with a focus on smart manufacturing.

In this thesis, mathematical modeling and simulation was applied as a tool to inform quantitative decision making in oncology drug discovery and development.

Promotor: Prof.dr. T. Schmidt, Co-Promotor: S.J.T. van Noort

Less than 1 in 10 drug candidates that enter phase 1 clinical trials actually gets approved for human use.

Promotores: W. Jiskoot, F. Ossendorp

The clinical potential of applying synthetic lethality to cancer treatment is famously demonstrated by the BRCA1/PARP1 paradigm: a tumor specific defect in BRCA1 – a component of the DNA double-strand break (DSB) repair pathway homologous recombination (HR) – results in a remarkable sensitivity to PARP1…

Promotor: Prof.dr. G.R. de Snoo

Soil is a home for an unbelievable diversity and abundance of microbial life that is essential for supporting life on our planet.